Success Stories: Healing Through Evidence: Nepalese Physician Secures EB-2 NIW with Premium Processing for Impactful Research in Internal Medicine
Client’s Testimonial:
“Thank you so much for your help on this matter.”
On June 4th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Internal Medicine Resident in the Field of Internal Medicine (Approval Notice).
General Field: Internal Medicine
Position at the Time of Case Filing: Internal Medicine Resident
Country of Origin: Nepal
State of Residence at the Time of Filing: New York
Approval Notice Date: June 4th, 2025
Processing Time: 23 days (Premium Processing Requested)
Case Summary:
In a rapidly evolving healthcare landscape, the United States continues to welcome professionals whose expertise directly supports the nation’s pressing health priorities. One such individual—a medical doctor and internal medicine researcher from Nepal—has recently secured EB-2 NIW (National Interest Waiver) approval with premium processing for her commitment to improving diagnostic accuracy and treatment strategies for chronic and infectious diseases.
Her story is not just about a successful petition. It is about how translational research, grounded in evidence and compassion, is shaping better health outcomes for diverse populations across the U.S.
Targeting Tomorrow’s Health Crisis with Today’s Data
The petitioner’s work lies at the intersection of internal medicine and public health. She focuses on evidence-based observational and translational research to improve patient outcomes in three main domains: ischemic stroke, infectious diseases, and preventive cardiovascular care.
Through her research, she has helped reveal critical risk factors such as hyperuricemia (elevated uric acid levels), linking it to ischemic strokes—a major cause of disability and death in the U.S. Her findings have informed strategies for early diagnosis and intervention, particularly in vulnerable and aging populations.
Her upcoming role as a primary care physician will also allow her to lead real-world clinical studies on treatment adherence, antimicrobial resistance, and the impact of lifestyle interventions in cardiovascular health.
A Record Marked by Recognition and Rigor
The client’s research has been published in five peer-reviewed journals and two preprint platforms, with over 25 citations to date. One of her most influential works—on the association between hyperuricemia and stroke—has been cited over 20 times and ranks among the top 10% most cited articles in Clinical Medicine for its publication year.
Her findings have been cited in works addressing cardiovascular risk models, genetic links to ischemic stroke, and comparative studies of dengue complications. This scholarly reach illustrates the real-world utility of her work in guiding both clinicians and health policy experts.
She has also collaborated on international projects, such as those led by Doctors on Wheels, with a focus on preventive cardiovascular care in underserved populations.
Voices from the Field
In a letter supporting her petition, one senior medical director emphasized:
“Her upcoming project will evaluate how targeted interventions in outpatient primary care can reduce the incidence of heart conditions… This work addresses a critical public health challenge of national importance.”
Strategic Use of Premium ProcessingRecognizing both the urgency and strength of her case, the petitioner opted for premium processing, which resulted in a swift adjudication. The petition, filed on May 12, 2025, received approval by June 4, 2025, demonstrating that meticulous documentation and a focused research agenda can yield rapid and successful outcomes under the EB-2 NIW category.
Why It Matters
The significance of her work goes beyond statistics. It touches on deeply human challenges—how to predict a stroke before it happens, how to manage a pandemic’s aftermath, how to support the mental health of healthcare workers.
In supporting her petition, we emphasized how her unique blend of clinical acumen, research innovation, and ongoing collaborations placed her in a position to lead real change—change that will reduce healthcare burdens and improve patient outcomes nationwide.